Clinical Trial: Clinical Trial Evaluate the Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension Health Supplements on Outpatients with Gastroesophageal Reflux Disease

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889246) titled 'Clinical Trial Evaluate the Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension Health Supplements on Outpatients with Gastroesophageal Reflux Disease' on March 15.

Brief Summary: This is an open-label, single-center clinical trial evaluating the efficacy and safety of Anvitra Gastric Suspension health supplements in adult patients with gastroesophageal reflux. Participants will be given Anvitra for 14 consecutive days and will continue to be monitored for 7 days after the intervention. The study aims to assess improvements in GERD symtoms, as well as monitor adverse events associated with the interventions. Data will...